Phase I trial of Vical's cytomegalovirus DNA vaccine in volunteers.
Latest Information Update: 02 Jul 2008
At a glance
- Drugs VCL 6365 (Primary) ; VCL-CT02 (Primary)
- Indications Cytomegalovirus infections
- Focus Adverse reactions; Pharmacodynamics
- 02 Jul 2008 New trial record.